Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation

BACKGROUND: Ablative therapy is a recommended treatment for hepatocellular carcinoma (HCC) not only for its effective eradication of tumors, but also for its induction of host immunity. However, the high 5-year recurrence rate after ablation underlines the poor understanding of the antitumor immunit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zang, Chaoran, Zhao, Yan, Liu, Guihai, Li, Kang, Qin, Ling, Zhang, Yuewei, Sun, Jianping, Wang, Qi, Ma, Liang, Zhao, Peng, Sun, Yu, Guo, Dandan, Yuan, Chunwang, Dong, Tao, Zhang, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813410/
https://www.ncbi.nlm.nih.gov/pubmed/36618423
http://dx.doi.org/10.3389/fimmu.2022.982578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813410/
https://www.ncbi.nlm.nih.gov/pubmed/36618423
http://dx.doi.org/10.3389/fimmu.2022.982578

Ejemplares similares